Bcal Diagnostics Ltd
BCAL Diagnostics Limited, a screening and diagnostic company, engages in developing a novel blood screening test to improve the diagnosis and monitoring of breast cancer. It develops BREASTESTplus, a first-in-class blood test designed to be used alongside standard mammogram in breast cancer screening. The company also develops BREASTEST, BCAL Diagnostics, and BCAL Dx. The company was incorporated… Read more
Bcal Diagnostics Ltd (BDX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: -0.999x
Based on the latest financial reports, Bcal Diagnostics Ltd (BDX) has a cash flow conversion efficiency ratio of -0.999x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.50 Million) by net assets (AU$2.50 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bcal Diagnostics Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Bcal Diagnostics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Bcal Diagnostics Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bcal Diagnostics Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jindo.Co. Ltd
KO:088790
|
-0.056x |
|
Minesto AB
ST:MINEST
|
-0.002x |
|
Proud Real Estate Public Company Limited
BK:PROUD
|
0.314x |
|
APTAMER GROUP LTD LS-001
F:P0J
|
N/A |
|
Ryvyl Inc
NASDAQ:RVYL
|
0.948x |
|
REMSleep Holdings Inc
OTCQB:RMSL
|
-0.265x |
|
Koroplast Temizlik Ambalaj Urunleri San. ve Dis Ticaret A.S.
IS:KRPLS
|
0.104x |
|
Vinalink International Freight Forwarders
VN:VNL
|
N/A |
Annual Cash Flow Conversion Efficiency for Bcal Diagnostics Ltd (2017–2024)
The table below shows the annual cash flow conversion efficiency of Bcal Diagnostics Ltd from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | AU$6.22 Million | AU$-6.14 Million | -0.986x | -87.28% |
| 2023-12-31 | AU$8.59 Million | AU$-4.52 Million | -0.527x | +54.60% |
| 2022-12-31 | AU$5.21 Million | AU$-6.05 Million | -1.160x | -247.35% |
| 2021-12-31 | AU$9.64 Million | AU$-3.22 Million | -0.334x | +0.16% |
| 2020-12-31 | AU$3.61 Million | AU$-1.21 Million | -0.334x | +77.81% |
| 2019-12-31 | AU$438.92K | AU$-661.65K | -1.507x | -40.18% |
| 2018-12-31 | AU$488.20K | AU$-525.01K | -1.075x | -118.70% |
| 2017-12-31 | AU$-81.85K | AU$-470.81K | 5.752x | -- |